Search For "pfizer and biontech"
Pfizer, BioNTech seek emergency authorization for COVID-19 vaccine for kid
Updated : 4 years, 3 months ago IST
New York [US], February 2 (ANI): The pharmaceutical companies, Pfizer and BioNTech, are seeking Emergency Use Authorization for their COVID-19 vaccine for use in children between six months and four years of age.
Read More
Pfizer, BioNTech not sure on vaccines' effectiveness on new COVID variant
Updated : 4 years, 6 months ago IST
Washington [US], November 27 (ANI): The pharmaceutical companies Pfizer and BioNTech on Saturday issued a statement stating that they are not sure whether their vaccines would be able to help in the treatment of the new COVID-19 variant 'Omicron'.
Read More
Pfizer asks Japan to approve COVID-19 vaccine for children aged 5-11
Updated : 4 years, 6 months ago IST
Washington [US], November 10 (ANI/Sputnik): Pharmaceutical companies Pfizer and BioNTech have filed an application with the Japanese Ministry of Health, Labour and Welfare for approval of their COVID-19 vaccine for children aged five to 11, according to a statement released on Wednesday.
Read More
Booster dose of COVID-19 vaccine 95.6 pc effective, say Pfizer, BioNTech
Updated : 4 years, 7 months ago IST
Washington [US], October 21 (ANI): Pfizer and BioNTech said on Thursday that a booster shot of their COVID-19 vaccine has shown 95.6 per cent efficacy when compared to those who did not receive the booster dose.
Read More
S. Korea reports 2,427 more COVID-19 cases
Updated : 4 years, 7 months ago IST
Seoul [South Korea], October 7 (ANI/Xinhua): South Korea reported 2,427 more cases of COVID-19 as of midnight Wednesday compared to 24 hours ago, raising the total number of infections to 325,804.
Read More
Pfizer and BioNTech announce submission of Initial data to US FDA to suppo
Updated : 4 years, 9 months ago IST
New York [US], August 17 (ANI): Pfizer and BioNTech announced that they have submitted Phase 1 data to the United States Food and Drug Administration (FDA) to support the evaluation of a third, or booster dose of the companies' COVID-19 vaccine for future licensure.
Read More
S. Korea reports 1,725 more COVID-19 cases, 203,926 in total
Updated : 4 years, 9 months ago IST
Seoul [South Korea], August 4 (ANI/Xinhua): South Korea reported 1,725 more cases of COVID-19 as of midnight Tuesday compared to 24 hours ago, raising the total number of infections to 203,926.
Read More
Pfizer, BioNTech to produce COVID-19 vaccine in South Africa
Updated : 4 years, 10 months ago IST
Washington [US], July 21 (ANI/Sputnik): Pfizer and BioNTech have signed an agreement with South Africa's Biovac Institute to produce the COVID-19 vaccine in South Africa for the African Union, Pfizer said in a statement on Wednesday.
Read More
UK approves Pfizer/BioNTech COVID shot for 12-15 year-olds
Updated : 4 years, 11 months ago IST
London [UK], June 4 (ANI): United Kingdom's drug regulator on Friday informed that it had approved the COVID-19 vaccine developed by Pfizer and BioNTech for use on 12 to 15 year-olds after similar clearances were given in the US and the EU.
Read More
Pfizer, BioNTech seek full approval of COVID-19 vaccine across US
Updated : 5 years ago IST
Washington [US], May 7 (ANI): Pharmaceutical giants Pfizer and BioNTech on Friday said that they have started the process for getting the US Food and Drug Administration (FDA) complete authorisation of its COVID-19 vaccine after having emergency use authorization for almost five months.
Read More
COVID-19: Committed to continuing to work with India to establish path for
Updated : 5 years ago IST
Washington [US], April 30 (ANI): Pfizer and BioNTech are firmly committed to working towards equitable and affordable access for their COVID-19 vaccine for people around the world including in India, the company said in a statement on Friday.
Read More
Pfizer asks for expansion of emergency use authorization to vaccinate 12 t
Updated : 5 years, 1 month ago IST
New York [US], April 10 (ANI): Pfizer and BioNTech requested the US Food and Drug Administration (FDA) on Friday for an amendment to its emergency use authorization of its Covid-19 vaccine, to expand its use for children ages 12 to 15 in the United States.
Read More